| Key role for a glutathione transferase in multiple-herbicide resistance in grass weeds I Cummins, DJ Wortley, F Sabbadin, Z He, CR Coxon, HE Straker, ... Proceedings of the National Academy of Sciences 110 (15), 5812-5817, 2013 | 323 | 2013 |
| Cyclin-dependent kinase (CDK) inhibitors: structure–activity relationships and insights into the CDK-2 selectivity of 6-substituted 2-arylaminopurines CR Coxon, E Anscombe, SJ Harnor, MP Martin, B Carbain, BT Golding, ... Journal of medicinal chemistry 60 (5), 1746-1767, 2017 | 106 | 2017 |
| PepTherDia: database and structural composition analysis of approved peptide therapeutics and diagnostics V D’Aloisio, P Dognini, GA Hutcheon, CR Coxon Drug Discovery Today 26 (6), 1409-1419, 2021 | 74 | 2021 |
| Fluorinated prolines as conformational tools and reporters for peptide and protein chemistry SJM Verhoork, PM Killoran, CR Coxon Biochemistry 57 (43), 6132-6143, 2018 | 62 | 2018 |
| The role of resveratrol on skeletal muscle cell differentiation and myotube hypertrophy during glucose restriction HF Dugdale, DC Hughes, R Allan, CS Deane, CR Coxon, JP Morton, ... Molecular and Cellular Biochemistry 444, 109-123, 2018 | 41 | 2018 |
| Trifluoroacetic Acid in 2,2,2‐Trifluoroethanol Facilitates SNAr Reactions of Heterocycles with Arylamines B Carbain, CR Coxon, H Lebraud, KJ Elliott, CJ Matheson, E Meschini, ... Chemistry–A European Journal 20 (8), 2311-2317, 2014 | 41 | 2014 |
| Physiological and pathological factors affecting drug delivery to the brain by nanoparticles Y Islam, AG Leach, J Smith, S Pluchino, CR Coxon, M Sivakumaran, ... Advanced Science 8 (11), 2002085, 2021 | 40 | 2021 |
| 2, 2, 2-Trifluoroethanol as a solvent to control nucleophilic peptide arylation D Gimenez, A Dose, NL Robson, G Sandford, SL Cobb, CR Coxon Organic & Biomolecular Chemistry 15 (19), 4081-4085, 2017 | 38 | 2017 |
| The application of perfluoroheteroaromatic reagents in the preparation of modified peptide systems D Gimenez, CA Mooney, A Dose, G Sandford, CR Coxon, SL Cobb Organic & Biomolecular Chemistry 15 (19), 4086-4095, 2017 | 38 | 2017 |
| Peptide based drug delivery systems to the brain Y Islam, AG Leach, J Smith, S Pluchino, CR Coxonl, M Sivakumaran, ... Nano Express 1 (1), 012002, 2020 | 35 | 2020 |
| Diaryl-and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions TJ Blackburn, S Ahmed, CR Coxon, J Liu, X Lu, BT Golding, RJ Griffin, ... Medchemcomm 4 (9), 1297-1304, 2013 | 33 | 2013 |
| Tuning the binding affinity and selectivity of perfluoroaryl‐stapled peptides by cysteine‐editing SJM Verhoork, CE Jennings, N Rozatian, J Reeks, J Meng, EK Corlett, ... Chemistry–A European Journal 25 (1), 177-182, 2019 | 29 | 2019 |
| Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles H Lebraud, CR Coxon, VS Archard, CM Bawn, B Carbain, CJ Matheson, ... Organic & biomolecular chemistry 12 (1), 141-148, 2014 | 21 | 2014 |
| A mild method for the synthesis of a novel dehydrobutyrine-containing amino acid AM Webster, CR Coxon, AM Kenwright, G Sandford, SL Cobb Tetrahedron 70 (31), 4661-4667, 2014 | 20 | 2014 |
| Synthesis of a novel tetrafluoropyridine-containing amino acid and tripeptide AS Hudson, A Hoose, CR Coxon, G Sandford, SL Cobb Tetrahedron Letters 54 (36), 4865-4867, 2013 | 18 | 2013 |
| Perfluoroaryl and perfluoroheteroaryl reagents as emerging new tools for peptide synthesis, modification and bioconjugation WDG Brittain, CR Coxon Chemistry–A European Journal 28 (7), e202103305, 2022 | 17 | 2022 |
| 2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase CJ Matheson, CR Coxon, R Bayliss, K Boxall, B Carbain, AM Fry, ... RSC Medicinal Chemistry 11 (6), 707-731, 2020 | 17 | 2020 |
| Expanding the Tool Kit of Automated Flow Synthesis: Development of In-line Flash Chromatography Purification CG Thomson, C Banks, M Allen, G Barker, CR Coxon, AL Lee, F Vilela The Journal of Organic Chemistry 86 (20), 14079-14094, 2021 | 16 | 2021 |
| Peptide-tetrapyrrole supramolecular self-assemblies: state of the art P Dognini, CR Coxon, WA Alves, F Giuntini Molecules 26 (3), 693, 2021 | 15 | 2021 |
| Development of brain targeting peptide based MMP-9 inhibiting nanoparticles for the treatment of brain diseases with elevated MMP-9 activity Y Islam, A Khalid, S Pluchino, M Sivakumaran, M Teixidò, A Leach, ... Journal of pharmaceutical sciences 109 (10), 3134-3144, 2020 | 14 | 2020 |
